Lazaros Belbasis
PhD
Early Career Research Fellow
Lazaros was awarded an Oxford Population Health Early Career Research Fellowship and joined the department in August 2022. His research focuses on applying modern epidemiological and statistical techniques to data from China Kadoorie Biobank and UK Biobank, to investigate causal risk factors for neurological diseases. The long-term aim of his research is to elucidate novel molecular pathways, to inform drug development and drug repurposing for disease prediction, prevention, and treatment.
Prior to moving to Oxford Population Health, Lazaros worked as a postdoctoral researcher at QUEST Center for Responsible Research (Berlin Institute of Health at Charité), where he was involved in research projects related to prediction modelling, research integrity and evidence synthesis.
Lazaros Belbasis obtained a medical degree (2015) and a PhD (2020) from the University of Ioannina. He also trained as a General Practitioner in Greece, obtaining his certificate of completion of training in 2021. He has been involved in medical research since the first year of his studies in the medical school. His PhD thesis focused on environmental risk factors for neurodegenerative disorders and was funded through a PhD scholarship by the Greek State Scholarships Foundation. His research was also funded by a Research Fellowship from the Hellenic Academy of Neuroimmunology.
Recent publications
-
Mapping and systematic appraisal of umbrella reviews in epidemiological research: a protocol for a meta-epidemiological study.
Journal article
Belbasis L. et al, (2023), Syst Rev, 12
-
Reproducibility of prediction models in health services research.
Journal article
Belbasis L. and Panagiotou OA., (2022), BMC Res Notes, 15
-
Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis
Journal article
Bellou V. et al, (2022), European Respiratory Journal, 59, 2002964 - 2002964
-
Conducting umbrella reviews.
Journal article
Belbasis L. et al, (2022), BMJ Med, 1
-
Tobacco Smoking and Risk for Pulmonary Fibrosis: A Prospective Cohort Study From the UK Biobank.
Journal article
Bellou V. et al, (2021), Chest, 160, 983 - 993